https://clinicaltrials.gov/ct2/show/NCT01976364?type=Intr&cond=Psoriasis&lupd_s=03%2F08%2F2019&lupd_d=14
Condition : Arthritis, Psoriatic
Interventions : Drug: Tofacitinib; Drug: Methotrexate; Drug: Placebo Methotrexate
Sponsor : Pfizer
Active, not recruiting
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
NCT01976364
Tue, 05 Nov 2013 12:00:00 EST
Last Update Posted: 03/22/19 09:27AM
